0
     

Report Added
Report already added
Consumer Health in Argentina

Consumer Health in Argentina

Argentina’s economic activity has recovered more quickly than expected, with an increase of 10.3% GDP in 2021, after a fall of 9.9% in 2020 in the context of the crisis unleashed by COVID-19. However, in 2022, the economy contracted more than expected in March, as the monthly inflation rate accelerated to its highest level in 20 years. It is projected that annual inflation will surpass 60% this year, as pandemic induced supply-demand mismatches are not yet fully solved, and this situation has be...

Euromonitor International's Consumer Health in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Argentina

List Of Contents And Tables

CONSUMER HEALTH IN ARGENTINA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2017-2022
Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 7 Distribution of Consumer Health by Format: % Value 2017-2022
Table 8 Distribution of Consumer Health by Format and Category: % Value 2022
Table 9 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Acetaminophen leads systemic analgesic growth after COVID-19
Topical analgesics benefited by an increase in product innovation
Bayer Argentina leadership weakened by the rise of acetaminophen boom
PROSPECTS AND OPPORTUNITIES
Acetaminophen sales expected to continue overperforming in the coming years
Genomma Lab Internacional continues to invest in analgesics
Players moving towards higher doses of ibuprofen, aspirin, and acetaminophen
CATEGORY DATA
Table 11 Sales of Analgesics by Category: Value 2017-2022
Table 12 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 13 NBO Company Shares of Analgesics: % Value 2018-2022
Table 14 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 15 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Cough, cold remedies recover as normal lifestyles resume after the pandemic
Restarting normal lifestyles help allergy remedies to rebound in 2022
Arcor and Mondelez maintain leads, while Procter & Gamble rides strong growth with its Vick portfolio
PROSPECTS AND OPPORTUNITIES
Consumption set to grow further as consumers return to outdoor lifestyles, although seasonality remains a key factor
Cetirizine likely to help drive antihistamines/allergy remedies (systemic) sales over the forecast period
Medicated confectionery to benefit from an emphasis on sugar-free products
CATEGORY DATA
Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Laboratorio Elea gains important ground driven by price and innovation
Antacids lose space to proton pump inhibitors, as omeprazole becomes a key ingredient
Unhealthy diets and ageing population support sales in digestive remedies in 2022
PROSPECTS AND OPPORTUNITIES
Demand set to rise, as growing working age population drives increase in digestive problems
Omeprazole within proton pump inhibitors is forecast to keep growing taking volume from antacids
Naturally-positioned digestive remedies are set to rise over the forecast period
CATEGORY DATA
Table 23 Sales of Digestive Remedies by Category: Value 2017-2022
Table 24 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 25 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 26 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 27 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sales rebound in 2022 as consumers return to normal lifestyles
New product developments help to fuel ongoing growth
Topical germicidals/antiseptics see boost from a return to more active, out-of-home activities
PROSPECTS AND OPPORTUNITIES
Further recuperation expected for sales of dermatologicals, supported by the return of in-store displays
New product development is expected to increase demand of dermatologicals during the forecast period
Online sales are predicted to continue improving in the coming years
CATEGORY DATA
Table 29 Sales of Dermatologicals by Category: Value 2017-2022
Table 30 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 31 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 32 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 34 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
NRT SMOKING CESSATION AIDS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Smoking prevalence sets off on a notable declining trend, boosting demand for NRT smoking cessation aids
NRT patches rebound strongly, while NRT gum maintains its popularity due to lower prices
GlaxoSmithKline Argentina maintains its dominant position in NRT sales
PROSPECTS AND OPPORTUNITIES
Demand for NRT smoking cessation aids set to grow further, thanks to increased awareness of the risks of smoking
Unstable economic scenario and a lower smoking prevalence may increase NRT sales further
New players and innovation to enter NRT smoking cessation aids may stimulate further growth in coming years
CATEGORY INDICATORS
Table 36 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
SLEEP AIDS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sales of sleep aids supported by increased, ongoing stress as result of economic instability
Megalabs’s GBO leadership driven by a wide portfolio of brands, with Elisium representation in-country
Natufarma maintains growth, driven by Valerian and Serenil brands in sleep aids
PROSPECTS AND OPPORTUNITIES
Sleep aids sales set to grow further, as consumers are increasingly anxious about the economy and global issues
Herbal/traditional sleep aids are set to grow at higher speed
E-commerce will increase its penetration in key urban cities
CATEGORY DATA
Table 43 Sales of Sleep Aids: Value 2017-2022
Table 44 Sales of Sleep Aids: % Value Growth 2017-2022
Table 45 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 46 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 47 Forecast Sales of Sleep Aids: Value 2022-2027
Table 48 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
EYE CARE IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Rising demand for eye care products driven by higher levels of screen time
Sanofi-Synthélabo de Argentina commands eye care with brand Irix in 2022
Chemists/pharmacies remains the main channel, due to government regulations banning OTC products
PROSPECTS AND OPPORTUNITIES
Increasing exposure on screens, driven by home working and ongoing habits, will support ongoing sales
Ageing population likely to support sales of eye care products in the forecast period
Players likely to develop ranges of standard eye care over the forecast period
CATEGORY DATA
Table 49 Sales of Eye Care by Category: Value 2017-2022
Table 50 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 51 NBO Company Shares of Eye Care: % Value 2018-2022
Table 52 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 53 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
WOUND CARE IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Normal activities after COVID-19 pandemic rebound wound care sales in 2022
Sales of sticking plasters/adhesive bandages mainly driven by seasonality and women
Beiersdorf (Argentina) dominates sticking plasters/adhesive bandages, while Johnson & Johnson de Argentina remains in second place
PROSPECTS AND OPPORTUNITIES
Consumer price-sensitivity set to remain high, as inflation further erodes purchasing power
Private label sales are expected to continue growing during the forecast period, due to lower prices
Return to normal lifestyles will continue to support wound care sales
CATEGORY DATA
Table 55 Sales of Wound Care by Category: Value 2017-2022
Table 56 Sales of Wound Care by Category: % Value Growth 2017-2022
Table 57 NBO Company Shares of Wound Care: % Value 2018-2022
Table 58 LBN Brand Shares of Wound Care: % Value 2019-2022
Table 59 Forecast Sales of Wound Care by Category: Value 2022-2027
Table 60 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Growing health and wellness trends support sales of vitamins
Vitamins C and D see solid growth, driven by higher rates of health awareness
Bayer intensifies its advertising budget, while Arcor increases its presence in supermarkets with new multivitamins
PROSPECTS AND OPPORTUNITIES
Consumption of vitamins will be driven by specialised nutrition segmented by age, gender, and daily activities
New branded players, as well as private labels, expected to bolster vitamins further over the forecast period
Online sales forecast to gain additional ground over the forecast period
CATEGORY DATA
Table 61 Sales of Vitamins by Category: Value 2017-2022
Table 62 Sales of Vitamins by Category: % Value Growth 2017-2022
Table 63 Sales of Multivitamins by Positioning: % Value 2017-2022
Table 64 NBO Company Shares of Vitamins: % Value 2018-2022
Table 65 LBN Brand Shares of Vitamins: % Value 2019-2022
Table 66 Forecast Sales of Vitamins by Category: Value 2022-2027
Table 67 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Dietary supplements benefit from health and wellness trends, aligned with expansion in health food shops
Innovation and a dynamic marketplace maintain expansion in dietary supplements’
TRB Pharma and Megalabs lead collagen sales boom in 2022
PROSPECTS AND OPPORTUNITIES
Dietary supplements’ competitive landscape likely to consolidate during the forecast period
Combination dietary supplements set to continue driving sales during the forecast period
Direct selling set to benefit from rising price-sensitivity and inflation
CATEGORY DATA
Table 68 Sales of Dietary Supplements by Category: Value 2017-2022
Table 69 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Table 70 Sales of Dietary Supplements by Positioning: % Value 2017-2022
Table 71 NBO Company Shares of Dietary Supplements: % Value 2018-2022
Table 72 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
Table 73 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Premium prices suppress stronger growth, whilst category remains supported by health and wellness trends
Weight loss supplements under government scrutiny due to high claims and low effectiveness
Abbot Laboratories Argentina leads with a dominant position in nutritional drinks, with Ensure and Glucerna brands
PROSPECTS AND OPPORTUNITIES
Direct selling likely to see growth in value shares during forecast period
Sales set to benefit from more age groups using weight management and wellbeing products
New products and their promotions likely to boost sales of weight management and wellbeing products in coming years
CATEGORY DATA
Table 75 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 76 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Table 77 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
Table 78 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
Table 79 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
SPORTS NUTRITION IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Stable performance, as the industry faces hikes in protein prices and lack of creatine
Sports nutrition benefits from the growth of e-commerce
Empresa De Nutricion Argentina undisputed leader benefited by a large scale of operations
PROSPECTS AND OPPORTUNITIES
Expanding consumer base set to drive growth in sports nutrition during the forecast period
High price hikes of protein may diminish further growth in sports nutrition
High inflation and import barriers may threaten future sales of sports nutrition
CATEGORY DATA
Table 81 Sales of Sports Nutrition by Category: Value 2017-2022
Table 82 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Table 83 NBO Company Shares of Sports Nutrition: % Value 2018-2022
Table 84 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
Table 85 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
Table 86 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Demand for herbal/traditional products to continue escalating as consumers seek prevention remedies
Arcor and Mondelez Argentina leads herbal/traditional products, while Hepatalgina holds top brand place since Elea buyout
Herbalife expands its herbal/traditional product portfolio, to make up for lost ground in other categories
PROSPECTS AND OPPORTUNITIES
Herbal/traditional products set to see healthy growth over the forecast period, in line with wellness trends
Ageing population and expansion of dietéticas set to further drive demand for herbal/traditional products
Consumers more likely to pay extra for natural products during the forecast period
CATEGORY DATA
Table 87 Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 88 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Table 89 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
Table 90 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
Table 91 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
Table 92 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sales of cough, cold and allergy (hay fever) remedies recover as lifestyles return to normal
Bayer Argentina remains the leading player in 2022 with its Aspirinetas Bayer brand retaining the lion’s share in paediatric aspirin
Arcor expands into paediatric consumer health with a USD20 million investment
PROSPECTS AND OPPORTUNITIES
High inflation and high prices likely to remain threats during the forecast period
Players will use different strategies to attract consumers in coming years
Health and wellness trend, as well as more shelf space in stores, set to boost sales in the forecast period
CATEGORY DATA
Table 93 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 94 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 95 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027

Report Title: Consumer Health in Argentina


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW